SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
wenjin
Lv2
120 积分
2023-10-25 加入
最近求助
最近应助
互助留言
Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses
2个月前
已完结
Exosomes derived from induced vascular progenitor cells promote angiogenesis in vitro and in an in vivo rat hindlimb ischemia model
2个月前
已完结
Microvesicle-mediated delivery of transforming growth factor β1 siRNA for the suppression of tumor growth in mice
2个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
4个月前
已完结
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial
8个月前
已完结
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
8个月前
已完结
Switch maintenance therapy with anlotinib after chemotherapy in unresectable or metastatic soft tissue sarcoma: a single-center retrospective study
8个月前
已完结
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
9个月前
已完结
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial
9个月前
已完结
Proportion of liver cancer cases and deaths attributable to potentially modifiable risk factors in China
10个月前
已完结
没有进行任何应助
下载不了
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论